Octant Bio's Co-Founder & CEO describes technology advances helping to navigate the biological complexity of multi-modal diseases

blonca9
Dec 26, 2023
1 min read

Sri Kosuri describes how Octant is using advances in biology, chemistry, multiplexing, and computing to create a platform to discover correctors for misfolding-mistrafficking disorders.

Recent Posts

See All

The Co-Director of Cardiff University's Medicines Discovery Institute talks about the specialized work that happens here in neuroscience, cancer, and beyond

SV Health Investors Managing Partner Kate Bingham shares the firm's investment philosophy and gives her take on the current state of life sciences in the United Kingdom and beyond

BIO International 2025: Oppenheimer's Head of Healthcare Investment Banking, Michael Margolis, discusses biotech sentiment, M&A, and what it is like to raise money today

Octant Bio's Co-Founder & CEO describes technology advances helping to navigate the biological complexity of multi-modal diseases

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight